Cost-effectiveness measures, methods, and policy implications from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for schizophrenia (Q50173812)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Cost-effectiveness measures, methods, and policy implications from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for schizophrenia |
scientific article |
Statements
1 reference
Cost-effectiveness measures, methods, and policy implications from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for schizophrenia (English)
1 reference
Robert A Rosenheck
1 reference
Jeffrey A Lieberman
1 reference
1 February 2007
1 reference
68
1 reference
2
1 reference
e05
1 reference